BioSpace News Archive

The MRI pulse oximeters are used to monitor the pulse rate and blood oxygen saturation during MRI scans. The number of people suffering from chronic diseases is rising rapidly.

The advances in the biotechnological fields have enabled researchers to identify the pathways which play a crucial role in the progression of cancer.

Albany NY, United States: In the recent times, the global market for immunohistochemistry has observed a noticeable rise and is anticipated to experience an upswing in its valuation in the years to come.

The growing clinical acceptance of drug-free alternatives to painkiller pharmaceuticals among the general population is a key driver for the evolution in the pain management devices market.

Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration has accepted the company’s supplemental Biologics License Application and has granted Priority Review for Actemra® intravenous for the treatment of COVID-19 in hospitalized adults who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation.

Skanska has signed a contract with Bon Secours - St. Francis Medical Center, Inc. to renovate and expand an acute care services facility in Midlothian, Virginia, USA.

Tessa Therapeutics Ltd., a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies and solid tumors, announced the appointment of Wilson W. Cheung as its chief financial officer effective April 1, 2022.

Protalix BioTherapeutics, Inc. and Chiesi Global Rare Diseases announced topline results from the BALANCE pivotal Phase III clinical trial evaluating pegunigalsidase alfa, 1 mg/kg, administered every two weeks, compared to agalsidase beta for the treatment of Fabry disease.

Starton Therapeutics Inc., a clinical stage biotechnology company transforming standard of care therapies with proprietary continuous delivery technology, announced that the US Food and Drug Administration has cleared an investigational new drug application for STAR-OLZ in Chemotherapy Induced Nausea and Vomiting.

OcuTerra Therapeutics, Inc. announced the appointment of eye care industry veteran Majid Anderesi, MD, as Vice President of Clinical and Medical Affairs.